2nd Annual Congress on Advances in Pharmaceutical Sciences

Oct 19-20, 2022

|

Madrid, Spain



Welcome message:

We gleefully invite you to attend the 2nd Annual Congress on Advances in Pharmaceutical Sciences which will take place in Madrid, Spain on October 19-20, 2022. It sets the goal of bringing together pharma professionals, researchers, scientists, students, and the Pharma industry to spread awareness and use of new technologies being used in the pharmaceutical industry. Medicine in the future will give everyone the ability to become their own best healer.

About conference:

The 2nd Annual Congress on Advances in Pharmaceutical Sciences aims at sharing new ideas and technologies amongst the professionals, industrialists, and students from research areas of Formulation Design, Drug Delivery and technology uses to share their recent studies, innovations, and applications and indulge in the interactive discussions which include prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions. This strategic conference will provide in-depth presentations and interactive sessions, for the possibility to network with like-minded professionals and discuss how to overcome the current challenges in pharmaceutical product synthesis and product development.

Here we learn and explore the latest research involved in the field of Pharmaceutical Sciences. Exchange ideas and network with leading healthcare experts. Exhibitors educate the industry about their newest products being launched in the market. "Medicine in the Future will give everyone the ability to become their own best Healer" Pharmaceutical Sciences is a dynamic and multi-interdisciplinary field concerned with the integration of biological, physical, and chemical sciences for the development and delivery of new drugs and therapies. It plays a vital role from the discovery of the drug to clinical evaluation and is being used safely and effectively by patients. Pharmaceutical science doesn’t just help relatively healthy people maintain their well-being. It gives people with serious illnesses the chance to regain their health.

 

Why attend:

The 2nd Annual Congress on Advances in Pharmaceutical Sciences conference brings experts together, leading researchers, scholars, scientists, and professors from fields of Health care and Pharmaceutical Sciences, Researchers, and other related areas to interact and exchange ideas and thoughts about the situation of the art technologies related to Pharmaceutics and Pharmaceutical Technology.

This conference would be your single best opportunity to reach the largest assembling of participants from the Pharma field. This 2nd Annual Congress on Advances in Pharmaceutical 2022 runs on the theme “Advances in Pharmaceutical technology”, which concedes that the conference will act as a platform for exploring the latest innovation in the field of Pharmaceutical science. The scientific event focuses on Pharmaceutics 2022 on the research which is currently being undertaken in the field of Pharmaceutical science including Pharmaceutical chemistry, drug discovery & designs, manufacturing, and so on. The Conference embraces Keynote speeches, Oral, Poster, and Video Presentations. The fostered participants can confirm their participation by registering in Pharmaceutics 2022. This conference will help the attendees in building strong professional knowledge of Pharmaceutical sciences. The Conference is organized under the belief that one-on-one interactions and discussions open door to innovations and inventions. We are proud facilitators of such an opportunity.

Targeted audience:
Drug Delivery Scientists
Product Development Specialists
Formulation / pre-formulation Scientists
Structure and Informatics Professionals
Pharmaceutical Development Experts
PK / PD Scientists
Medicinal pharmaceuticals
External Manufacturing Companies
Scientists & Biotechnology Experts
Academicians, Researchers & Students
Nano Science and Nano Technology Researchers
Drug Delivery Associations and Societies
Pharmaceutical Researchers
Directors, Presidents, CEOs of Organizations/Companies
Noble Laureates in Health Care and Medicine
Medical Equipment and Pharmaceuticals Companies
Materials and tools companies

Abstract submission details: [email protected]

Market analysis:

 Pharmaceutical market research analysis (PMRA) can validate a product’s potential reach and its market penetration capabilities. Those companies use it to monitor the competition, identify potential and value their products. The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent Pharma market research report by The Business Research Company. This is an accelerated pace compared to 5.2% for the years before 2017 but is slower than the other two large healthcare segments, medical equipment, and healthcare services. The Board of Pharmaceutical Sciences (BPS) of the International Pharmaceutical Federation (FIP) has given a view on the future of pharmaceutical sciences in 2020. The global pharmaceutical market is set to reach 10.27 billion USD by 2025. The market is expected to see a growth at 13.1% CAGR owing to the increasing incidence of Adverse Drug Reactions. Market analysis of pharmareactions being manufactured globally in (USD).

Global Bussiness and Research values: 

In 2017, the global pharmaceutical market was valued at 1,135 billion U.S. dollars. The market has experienced ongoing growth over the last decade and is predicted to continue this trend. For the European Union, a growth rate of 3.1 percent until 2022 is estimated, and for North America 5.4 percent.

Trends in R&D Spending and New Drug Development:

Private spending on pharmaceutical R&D and the approval of new drugs have both increased markedly in recent years, resuming a decades-long trend that was interrupted in 2008 as generic versions of some top-selling drugs became available. In particular, spending on drug R&D increased by nearly 50 percent between 2015 and 2019. Many of the drugs approved in recent years are high-priced specialty drugs for relatively small numbers of potential patients. By contrast, the top-selling drugs of the 1990s were lower-cost drugs with large patient populations.

Program Overview